跳至主要内容
临床试验/JPRN-UMIN000002267
JPRN-UMIN000002267未知未知

Investigation optimal dosing of insulin detemir after switching from other basal insulin by using CGM system - Investigation optimal dosing of insulin detemir after switching from other basal insulin by using CGM system

Tokyo Women's Medical University0 个研究点目标入组 20 人开始时间: 2009年8月1日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Pregnant, or intention of becoming pregnant. 2.Patients who are judged by investigators as inappropriate subject to participant this trail.

研究者

发起方
Tokyo Women's Medical University

相似试验

已完成
不适用
Insulin dosing for fat and protein in people with Type 1 Diabetes using insulin injections.Diet and Nutrition - Other diet and nutrition disordersMetabolic and Endocrine - DiabetesType 1 Diabetes
ACTRN12618002030257Diabetes Australia27
已完成
不适用
The study of algorithm for insulin dose after the change to insulin glargine U300 (LANTUS-XR) for type 2 diabetic patients with poor glucose control under insulin therapy.Type 2 diabetes mellitus
JPRN-UMIN000024738Matsuyama shimin hospital100
已完成
不适用
What is the optimal dose of insulin for the protein content of a meal in individuals with type 1 diabetes mellitus using intensive insulin therapyType 1 Diabetes Mellitus
ACTRN12616000222448Hunter Medical Research Institute32
进行中(未招募)
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioType 2 diabetesMedDRA version: 9.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus
EUCTR2007-005317-19-GBovo Nordisk A/S940
进行中(未招募)
不适用
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extension - ND
EUCTR2007-005317-19-ITOVO NORDISK940
Investigation optimal dosing of insulin detemir... | 临床试验